Eckert & Ziegler
Eckert & Ziegler SE is a German medical technology and isotope engineering company specializing in the processing of radioisotopes and the manufacture of radiopharmaceutical components and sealed radiation sources. The group operates through two primary reporting segments: Medical, which supplies pharmaceutical-grade radioisotopes such as gallium-68, actinium-225, and lutetium-177 alongside automated synthesis modules for cancer diagnosis and targeted radioligand therapy, and Isotope Products, which provides calibration standards and industrial radiation sources for nuclear imaging, process control, and environmental monitoring. Revenue is driven primarily by global expansion in nuclear medicine oncology procedures, multi-year supply agreements with biopharmaceutical developers, and recurring sales of consumables and radiochemistry equipment to hospitals and clinics. Operating specialized production facilities across Europe and North America, Eckert & Ziegler employs over one thousand staff and generates annual revenue exceeding 300 million euros. Its regulatory licenses and isotope processing expertise create high barriers to entry in medical radiochemistry. Headquartered in Berlin, Germany, Eckert & Ziegler SE is publicly listed on the Frankfurt Stock Exchange under the ticker EUZ.
9 of the funds FundTelligence covers report a position in Eckert & Ziegler.
- Sector
- Health Care
- Country
- Germany
- Funds holding it
- 9
Funds holding Eckert & Ziegler
- Lannebo Europa Småbolag — Lannebo · 1.74 % (full portfolio disclosed, June 2026)
- Lannebo Global Småbolag — Lannebo · 0.95 % (full portfolio disclosed, June 2026)
- JPM Europe Dynamic Small Cap Fund — JPM · 0.49 % (full portfolio disclosed, December 2025)
- JPM Europe Sustainable Small Cap Equity Fund — JPM · 0.42 % (full portfolio disclosed, June 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.07 % (full portfolio disclosed, October 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.06 % (full portfolio disclosed, September 2026)
- DNB Global Enhanced Small Cap — DNB · 0.01 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)
Showing the 8 largest of 9 funds holding it.